Projects overview

Sort by

Toggle all information

IN-ARMOR | THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR]

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

ITHEMYC | Novel immunotherapies for tuberculosis and other mycobacterial diseases

01-06-2023

-

31-05-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

ARTiDe | Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)

01-07-2023

-

30-06-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

PHOENIX | NANOMEDICINE FOR ORGAN TRANSPLANTATION TOLERANCE (PHOENIX)

01-04-2023

-

31-03-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

NEXGEN-PD | Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease

01-04-2023

-

31-03-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

FIBROTARGET | Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

01-04-2023

-

31-03-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

TiilT | Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites

01-06-2023

-

31-05-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

MITI 2 | Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs
Powered by Chris Decubber BV